首页 › 基金 › Boxer Capital Management, LLC › INO
Boxer Capital Management, LLC 对 INO 的持仓历史
INOVIO PHARMACEUTICALS · 医疗保健
Boxer Capital Management, LLC 在 Q2 2026 的 13F 申报中披露持有 INO(INOVIO PHARMACEUTICALS)2,844,994 股,市值约 US$3.1M,约占其申报组合的 0.24%,在其申报持仓中市值排名第 48 位。 Boxer Capital Management, LLC 最近 4 个申报季度中有 4 个季度披露了 INO 持仓,最早可追溯至 Q3 2025。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Boxer Capital Management, LLC 对 INO 的持仓演变
Boxer Capital Management, LLC 于 Q3 2025 首次披露 INO 持仓:2,300,000 股(约 US$5.4M)。 在 4 次申报中,Boxer Capital Management, LLC 2 次增持、1 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 2,844,994 股、市值约 US$3.1M,环比增持 474,872 股。。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2025 | 2.30M | $5.38M | 新进 |
| Q4 2025 | 2.42M | $4.21M | 增持 |
| Q1 2026 | 2.37M | $4.12M | 减持 |
| Q2 2026 | 2.84M | $3.13M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 INO 与 13F 数据
INO(INOVIO PHARMACEUTICALS)属于医疗保健行业。我们追踪的基金中还有 26 只申报持有 INO。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
更多关于 Boxer Capital Management, LLC
常见问题
How long has Boxer Capital Management, LLC held INO?
Boxer Capital Management, LLC has disclosed INO holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
What is Boxer Capital Management, LLC's current position in INO?
As of Q2 2026, Boxer Capital Management, LLC holds 2.84M shares of INO (INOVIO PHARMACEUTICALS), valued at $3.13M, representing 0.24% of its reported portfolio and ranking #48.
Has Boxer Capital Management, LLC been buying or selling INO?
In the latest 13F filing (Q2 2026), Boxer Capital Management, LLC increased its position in INO.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.